The latest announcement is out from Encompass Health (EHC).
The company has stated that certain information is not to be considered officially filed under financial regulations and won’t be included in official filings unless specifically referenced. They also highlight that they don’t provide GAAP-based guidance due to unpredictable factors such as legal settlements, market adjustments, and restructuring costs. However, they can predict certain costs for 2024, including interest expenses and debt amortization, which will be used to adjust EBITDA calculations.
For detailed information about EHC stock, go to TipRanks’ Stock Analysis page.
